vs
Side-by-side financial comparison of Artisan Partners Asset Management Inc. (APAM) and Bio-Techne (TECH). Click either name above to swap in a different company.
Artisan Partners Asset Management Inc. is the larger business by last-quarter revenue ($335.5M vs $295.9M, roughly 1.1× Bio-Techne). Artisan Partners Asset Management Inc. runs the higher net margin — 35.2% vs 12.8%, a 22.3% gap on every dollar of revenue. On growth, Artisan Partners Asset Management Inc. posted the faster year-over-year revenue change (12.9% vs -6.4%). Over the past eight quarters, Artisan Partners Asset Management Inc.'s revenue compounded faster (12.7% CAGR vs 4.2%).
Artisan Partners is an American asset management company headquartered in Milwaukee, Wisconsin. Outside the United States, the company has offices in Dublin, Hong Kong, London, Singapore and Sydney.
Bio-Techne Corporation is an American life sciences company that develops, manufactures and sells life science reagents, instruments and services for the research, diagnostic, and bioprocessing markets.
APAM vs TECH — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $335.5M | $295.9M |
| Net Profit | $118.1M | $38.0M |
| Gross Margin | — | 64.6% |
| Operating Margin | 39.2% | 18.4% |
| Net Margin | 35.2% | 12.8% |
| Revenue YoY | 12.9% | -6.4% |
| Net Profit YoY | 34.9% | 68.3% |
| EPS (diluted) | $1.36 | $0.24 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $335.5M | $295.9M | ||
| Q3 25 | $301.3M | — | ||
| Q2 25 | $282.7M | $317.0M | ||
| Q1 25 | $277.1M | $316.2M | ||
| Q4 24 | $297.1M | $297.0M | ||
| Q3 24 | $279.6M | $289.5M | ||
| Q2 24 | $270.8M | $306.1M | ||
| Q1 24 | $264.4M | $303.4M |
| Q4 25 | $118.1M | $38.0M | ||
| Q3 25 | $66.8M | — | ||
| Q2 25 | $67.6M | $-17.7M | ||
| Q1 25 | $61.1M | $22.6M | ||
| Q4 24 | $87.5M | $34.9M | ||
| Q3 24 | $73.0M | $33.6M | ||
| Q2 24 | $57.6M | $40.6M | ||
| Q1 24 | $59.5M | $49.1M |
| Q4 25 | — | 64.6% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 62.7% | ||
| Q1 25 | — | 67.9% | ||
| Q4 24 | — | 65.3% | ||
| Q3 24 | — | 63.2% | ||
| Q2 24 | — | 66.4% | ||
| Q1 24 | — | 67.4% |
| Q4 25 | 39.2% | 18.4% | ||
| Q3 25 | 33.8% | — | ||
| Q2 25 | 28.2% | -7.5% | ||
| Q1 25 | 31.2% | 12.2% | ||
| Q4 24 | 36.7% | 16.0% | ||
| Q3 24 | 33.3% | 13.8% | ||
| Q2 24 | 32.0% | 15.0% | ||
| Q1 24 | 29.4% | 22.1% |
| Q4 25 | 35.2% | 12.8% | ||
| Q3 25 | 22.2% | — | ||
| Q2 25 | 23.9% | -5.6% | ||
| Q1 25 | 22.1% | 7.1% | ||
| Q4 24 | 29.5% | 11.7% | ||
| Q3 24 | 26.1% | 11.6% | ||
| Q2 24 | 21.3% | 13.3% | ||
| Q1 24 | 22.5% | 16.2% |
| Q4 25 | $1.36 | $0.24 | ||
| Q3 25 | $0.93 | — | ||
| Q2 25 | $0.94 | $-0.11 | ||
| Q1 25 | $0.82 | $0.14 | ||
| Q4 24 | $0.99 | $0.22 | ||
| Q3 24 | $1.03 | $0.21 | ||
| Q2 24 | $0.80 | $0.26 | ||
| Q1 24 | $0.84 | $0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $172.9M |
| Total DebtLower is stronger | $190.0M | $260.0M |
| Stockholders' EquityBook value | $438.8M | $2.0B |
| Total Assets | $1.6B | $2.5B |
| Debt / EquityLower = less leverage | 0.43× | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $172.9M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $162.2M | ||
| Q1 25 | — | $140.7M | ||
| Q4 24 | — | $177.5M | ||
| Q3 24 | — | $187.5M | ||
| Q2 24 | — | $152.9M | ||
| Q1 24 | — | $145.3M |
| Q4 25 | $190.0M | $260.0M | ||
| Q3 25 | $190.0M | — | ||
| Q2 25 | $200.0M | $346.0M | ||
| Q1 25 | $200.0M | $330.0M | ||
| Q4 24 | $200.0M | $300.0M | ||
| Q3 24 | $200.0M | $300.0M | ||
| Q2 24 | $200.0M | $319.0M | ||
| Q1 24 | $200.0M | $389.0M |
| Q4 25 | $438.8M | $2.0B | ||
| Q3 25 | $402.1M | — | ||
| Q2 25 | $381.8M | $1.9B | ||
| Q1 25 | $356.5M | $2.0B | ||
| Q4 24 | $388.9M | $2.1B | ||
| Q3 24 | $372.1M | $2.1B | ||
| Q2 24 | $341.2M | $2.1B | ||
| Q1 24 | $320.3M | $2.0B |
| Q4 25 | $1.6B | $2.5B | ||
| Q3 25 | $1.6B | — | ||
| Q2 25 | $1.4B | $2.6B | ||
| Q1 25 | $1.4B | $2.6B | ||
| Q4 24 | $1.6B | $2.7B | ||
| Q3 24 | $1.6B | $2.7B | ||
| Q2 24 | $1.5B | $2.7B | ||
| Q1 24 | $1.5B | $2.7B |
| Q4 25 | 0.43× | 0.13× | ||
| Q3 25 | 0.47× | — | ||
| Q2 25 | 0.52× | 0.18× | ||
| Q1 25 | 0.56× | 0.16× | ||
| Q4 24 | 0.51× | 0.14× | ||
| Q3 24 | 0.54× | 0.14× | ||
| Q2 24 | 0.59× | 0.15× | ||
| Q1 24 | 0.62× | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $172.0M | — |
| Free Cash FlowOCF − Capex | $171.6M | — |
| FCF MarginFCF / Revenue | 51.2% | — |
| Capex IntensityCapex / Revenue | 0.1% | — |
| Cash ConversionOCF / Net Profit | 1.46× | — |
| TTM Free Cash FlowTrailing 4 quarters | $420.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $172.0M | — | ||
| Q3 25 | $40.4M | — | ||
| Q2 25 | $50.9M | $98.2M | ||
| Q1 25 | $157.9M | $41.1M | ||
| Q4 24 | $372.8M | $84.3M | ||
| Q3 24 | $112.8M | $63.9M | ||
| Q2 24 | $75.9M | $75.5M | ||
| Q1 24 | $147.0M | $81.0M |
| Q4 25 | $171.6M | — | ||
| Q3 25 | $40.4M | — | ||
| Q2 25 | $50.9M | $93.3M | ||
| Q1 25 | $157.7M | $31.0M | ||
| Q4 24 | $371.3M | $77.5M | ||
| Q3 24 | $112.4M | $54.7M | ||
| Q2 24 | $75.2M | $57.5M | ||
| Q1 24 | $146.9M | $64.5M |
| Q4 25 | 51.2% | — | ||
| Q3 25 | 13.4% | — | ||
| Q2 25 | 18.0% | 29.4% | ||
| Q1 25 | 56.9% | 9.8% | ||
| Q4 24 | 125.0% | 26.1% | ||
| Q3 24 | 40.2% | 18.9% | ||
| Q2 24 | 27.8% | 18.8% | ||
| Q1 24 | 55.6% | 21.3% |
| Q4 25 | 0.1% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | 1.5% | ||
| Q1 25 | 0.1% | 3.2% | ||
| Q4 24 | 0.5% | 2.3% | ||
| Q3 24 | 0.1% | 3.2% | ||
| Q2 24 | 0.2% | 5.9% | ||
| Q1 24 | 0.0% | 5.4% |
| Q4 25 | 1.46× | — | ||
| Q3 25 | 0.60× | — | ||
| Q2 25 | 0.75× | — | ||
| Q1 25 | 2.58× | 1.82× | ||
| Q4 24 | 4.26× | 2.42× | ||
| Q3 24 | 1.54× | 1.90× | ||
| Q2 24 | 1.32× | 1.86× | ||
| Q1 24 | 2.47× | 1.65× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
APAM
Segment breakdown not available.
TECH
| Diagnostics And Spatial Biology | $81.2M | 27% |
| EMEA Excluding UK | $75.4M | 25% |
| Other | $42.4M | 14% |
| Instruments | $29.6M | 10% |
| APAC Excluding Greater China | $22.7M | 8% |
| Services | $22.3M | 8% |
| GB | $13.7M | 5% |
| Royalty | $8.5M | 3% |
